Author details

Full Name

Lianbo Yu

Affiliation

The Ohio State University

ORCID

Career Start Year

1997

Papers

163

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36287107	HDAC1 regulates the chromatin landscape to control transcriptional dependencies in chronic lymphocytic leukemia.	Blood Adv	2023
37384650	Expression of microRNAs and their target genes in melanomas originating from gynecologic sites.	PLoS One	2023
36979691	Rapid Biomarker-Based Diagnosis of Fibromyalgia Syndrome and Related Rheumatologic Disorders by Portable FT-IR Spectroscopic Techniques.	Biomedicines	2023
37327244	HTLV-1 Hbz protein, but not hbz mRNA secondary structure, is critical for viral persistence and disease development.	PLoS Pathog	2023
36819050	The PRMT5 inhibitor EPZ015666 is effective against HTLV-1-transformed T-cell lines <i>in vitro</i> and <i>in vivo</i>.	Front Microbiol	2023
36623238	Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations.	JCO Precis Oncol	2023
36609611	Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformation.	Nat Commun	2023
36148789	Cell-intrinsic melanin fails to protect melanocytes from ultraviolet-mutagenesis in the absence of epidermal melanin.	Pigment Cell Melanoma Res	2023
36202232	Expression Patterns of microRNAs and Associated Target Genes in Ulcerated Primary Cutaneous Melanoma.	J Invest Dermatol	2023
34599880	METTL3 Regulates Liver Homeostasis, Hepatocyte Ploidy, and Circadian Rhythm-Controlled Gene Expression in Mice.	Am J Pathol	2022
35856214	[Research progress in the methodology used in phenome-wide association studies].	Zhonghua Liu Xing Bing Xue Za Zhi	2022
35533313	Stromal p53 Regulates Breast Cancer Development, the Immune Landscape, and Survival in an Oncogene-Specific Manner.	Mol Cancer Res	2022
35788359	Molecular profiling of kidney compartments from serial biopsies differentiate treatment responders from non-responders in lupus nephritis.	Kidney Int	2022
36474635	Influenza A virus modulates ACE2 expression and SARS-CoV-2 infectivity in human cardiomyocytes.	iScience	2022
36250792	CEDA: integrating gene expression data with CRISPR-pooled screen data identifies essential genes with higher expression.	Bioinformatics	2022
36380319	Preclinical evaluation of combination nemtabrutinib and venetoclax in chronic lymphocytic leukemia.	J Hematol Oncol	2022
33229401	Characterization of Clonal Evolution in Microsatellite Unstable Metastatic Cancers through Multiregional Tumor Sequencing.	Mol Cancer Res	2021
33586683	Paracardial fat remodeling affects systemic metabolism through alcohol dehydrogenase 1.	J Clin Invest	2021
33659005	A Novel Inflammatory Dendritic Cell That Is Abundant and Contiguous to T Cells in the Kidneys of Patients With Lupus Nephritis.	Front Immunol	2021
35056977	Amino Acid Nanofibers Improve Glycemia and Confer Cognitive Therapeutic Efficacy to Bound Insulin.	Pharmaceutics	2021
34590014	Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research Autopsy.	JTO Clin Res Rep	2021
34469478	Loss of miR-1469 expression mediates melanoma cell migration and invasion.	PLoS One	2021
34816100	Stabilin receptors clear LPS and control systemic inflammation.	iScience	2021
34534729	Characterization of inflammatory changes in the breast cancer associated adipose tissue and comparison to the unaffected contralateral breast.	Surg Oncol	2021
34712230	Effect of Immune Checkpoint Blockade on Myeloid-Derived Suppressor Cell Populations in Patients With Melanoma.	Front Immunol	2021
34027313	Antibody Conjugation of Fluorescent Nanodiamonds for Targeted Innate Immune Cell Activation.	ACS Appl Nano Mater	2021
31582534	Ibrutinib Potentiates Antihepatocarcinogenic Efficacy of Sorafenib by Targeting EGFR in Tumor Cells and BTK in Immune Cells in the Stroma.	Mol Cancer Ther	2020
33615073	Establishing a Case for Anti-complement Therapy in Membranous Nephropathy.	Kidney Int Rep	2020
34337428	Impact of age-related T cell dynamics on the identification of biomarkers predictive of immunotherapy discontinuation: a prospective cohort study.	Aging Cancer	2020
32051256	Variants in <i>LRRC34</i> reveal distinct mechanisms for predisposition to papillary thyroid carcinoma.	J Med Genet	2020
33057112	Differentiating Staphylococcus infection-associated glomerulonephritis and primary IgA nephropathy: a mass spectrometry-based exploratory study.	Sci Rep	2020
33203992	Characterizing the function of EPB41L4A in the predisposition to papillary thyroid carcinoma.	Sci Rep	2020
32977582	Transcriptomics-Based Drug Repurposing Approach Identifies Novel Drugs against Sorafenib-Resistant Hepatocellular Carcinoma.	Cancers (Basel)	2020
32361724	Association of Epigenetic Age and p16INK4a With Markers of T-Cell Composition in a Healthy Cohort.	J Gerontol A Biol Sci Med Sci	2020
32489246	RNA-Seq Reproducibility Assessment of the Sequencing Quality Control Project.	Cancer Inform	2020
32429934	Power analysis for RNA-Seq differential expression studies using generalized linear mixed effects models.	BMC Bioinformatics	2020
32429929	Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer.	BMC Cancer	2020
30523152	Metabolic fingerprinting for diagnosis of fibromyalgia and other rheumatologic disorders.	J Biol Chem	2019
31699991	Protein lysine 43 methylation by EZH1 promotes AML1-ETO transcriptional repression in leukemia.	Nat Commun	2019
31751415	Comparative studies of two generations of NanoString nCounter System.	PLoS One	2019
31861977	Fully moderated t-statistic in linear modeling of mixed effects for differential expression analysis.	BMC Bioinformatics	2019
29800348	Immune gene expression in kidney biopsies of lupus nephritis patients at diagnosis and at renal flare.	Nephrol Dial Transplant	2019
31296529	EÎ¼-TCL1xMyc: A Novel Mouse Model for Concurrent CLL and B-Cell Lymphoma.	Clin Cancer Res	2019
31547518	Rethinking Lupus Nephritis Classification on a Molecular Level.	J Clin Med	2019
31515494	Assessment of temporal functional changes and miRNA profiling of human iPSC-derived cardiomyocytes.	Sci Rep	2019
31371345	Tumor heterogeneity and acquired drug resistance in FGFR2-fusion-positive cholangiocarcinoma through rapid research autopsy.	Cold Spring Harb Mol Case Stud	2019
31338557	An IL-15-based superagonist ALT-803 enhances the NK cell response to cetuximab-treated squamous cell carcinoma of the head and neck.	Cancer Immunol Immunother	2019
31097475	A Microfluidic Chip Enables Isolation of Exosomes and Establishment of Their Protein Profiles and Associated Signaling Pathways in Ovarian Cancer.	Cancer Res	2019
30834643	Nontuberculous mycobacterium M. avium infection predisposes aged mice to cardiac abnormalities and inflammation.	Aging Cell	2019
30962859	Increased breast cancer risk in women with neurofibromatosis type 1: a meta-analysis and systematic review of the literature.	Hered Cancer Clin Pract	2019

1 - 50 of 163

Tuo Zhang

Weill Cornell Medical College.

Career Start Year 2013

Number of shared co-authors 0

Ganiraju C Manyam

the University of Texas MD Anderson Cancer Center

Career Start Year 2009

Number of shared co-authors 1

Xinmin Li

University of California los angeles

Career Start Year 2008

Number of shared co-authors 1

Qiyuan Li

National Institute of Data Science in Health and Medicine, Xiamen University

Career Start Year 2008

Number of shared co-authors 1

Matti Nykter

Prostate Cancer Research Center, Tampere University and Tays Cancer Center

Career Start Year 2006

Number of shared co-authors 2

Maggie Cam

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 2005

Number of shared co-authors 0

Henry Yang

Cancer Science Institute of Singapore, National University of Singapore

Career Start Year 2005

Number of shared co-authors 0

Andrew V Kossenkov

The Wistar Institute

Career Start Year 2003

Number of shared co-authors 0

Jianmin Wang

Roswell Park Comprehensive Cancer Center

Career Start Year 2003

Number of shared co-authors 1

Lixia Diao

The University of Texas MD Anderson Cancer Center

Career Start Year 2003

Number of shared co-authors 2

Leslie Cope

Johns Hopkins University School of Medicine

Career Start Year 2003

Number of shared co-authors 1

Olivier Elemento

Meyer Cancer Center

Career Start Year 2002

Number of shared co-authors 4

Joel S Parker

Lineberger Cancer Center, University of North Carolina

Career Start Year 2002

Number of shared co-authors 0

Yuelin J Zhu

National Cancer Institute, National Institutes of Health

Career Start Year 2002

Number of shared co-authors 0

Michael Slifker

Fox Chase Cancer Center

Career Start Year 2002

Number of shared co-authors 0

Syed Haider

Institute of Cancer Research

Career Start Year 2002

Number of shared co-authors 3

Mikhail G Dozmorov

Virginia Commonwealth University

Career Start Year 2001

Number of shared co-authors 0

Ludmila Danilova

Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine

Career Start Year 2001

Number of shared co-authors 1

Yidong Chen

The University of Texas Health Science Center at San Antonio

Career Start Year 2001

Number of shared co-authors 0

Yan W Asmann

Mayo Clinic

Career Start Year 2000

Number of shared co-authors 0

David K Crossman

University of Alabama at Birmingham

Career Start Year 2000

Number of shared co-authors 2

Celine Lefebvre

The Scripps Research Institute

Career Start Year 1999

Number of shared co-authors 0

Dongquan Chen

University of Alabama at Birmingham

Career Start Year 1997

Number of shared co-authors 0

Benedikt Brors

German Cancer Research Center (DKFZ)

Career Start Year 1997

Number of shared co-authors 5

Agnes Viale

Memorial Sloan Kettering Cancer Center

Career Start Year 1996

Number of shared co-authors 2

Woong-Yang Park

Samsung Genome Institute, Samsung Medical Center

Career Start Year 1995

Number of shared co-authors 0

Nan Deng

Cedars-Sinai Medical Center

Career Start Year 1992

Number of shared co-authors 0

Wenbin Wei

Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield

Career Start Year 1991

Number of shared co-authors 0

Luigi Marchionni

Weill-Cornell School of Medicine

Career Start Year 1989

Number of shared co-authors 0

Sean Davis

Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington

Career Start Year 1974

Number of shared co-authors 1

row(s) 1 - 30 of 30